-
Nitrosamine impurities
Nitrosamine impurities are compounds containing N-nitroso structures that are highly carcinogenic. The problem of contamination with such impurities has spread from valsartan to a wide range of dru...
See More
-
New Product--Segmalutide Impurity
The patent for the sequence structure and use of semaglutide will expire in March 2026 in China, and dozens of companies have started the filing of semaglutide.have started the filing of semaglutid...
See More
-
Lincomycin Impurity
Common lincomycin impurities include lincomycin hydrochloride, lincomycin sulfone, and lincomycin N-oxide. The study of these impurities can control potentially harmful substances in pharmaceutical...
See More
-
special recommened——Crisaborole Impurity
Crisaborole is a nonsteroidal phosphodiesterase 4 (PDE-4) inhibitor used primarily for the treatment of mild to moderate atopic dermatitis.SZEB suppliesa full set of Crisaborole impurity for ...
See More
-
a “miracle helper” on the way to anti-infection—— Clindamycin...
Clindamycin has strong anti-infective ability and wide therapeutic range, and is widely used in the treatment of various types of infections....
See More
-
a new glycemic control chioce:Fogtaliptine Benzoate Tablets...
Recently, a new glycemic control medicine, fotagliptine Benzoate Tablets , has been approved for marketing, bringing a new choice of medication for patients with type 2 diabetes. fotagliptine benzo...
See More
-
Hengrui‘s Paclitaxel for injection is approved in the United States...
The study of paclitaxel impurities is of great significance to ensure the safety and efficacy of the drug. Through continuous technological innovation and strict quality control standards, the produ...
See More
-
Ezetimibe impurity
As an important non-statin lipid-lowering drug, Ezetimibe impurity is crucial for research and quality control, SZEB supplies Ezetimibe impurity, which can provide comprehensive solutions for t...
See More
-
New impurity | Canagliflozin impurity 8
The main impurity Canagliflozin Impurity 8, CAS number: 90-80-2 Molecular formula: C6H10O6 Molecular weight: 178.14 Chemical formula::(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)...
See More
-
Iohexol--drugs for medical imaging diagnosis...
Therefore, research on iohexol impurities pharmaceutical quality control is very critical, most of the current production and quality control of iohexol is based on the European Pharmacopoeia metho...
See More
-
Baricitinib —— the solution to the problem of hair loss....
Jerry Shapiro said in WCD 2023 Oral Presentation. that for patients with a shorter course of alopecia areata, regardless of severity, the proportion of patients who get a clinical response aft...
See More
-
Drug Impurity ——glycoconjugate
Sugar compounds in drug impurity pairs include various types such as monosaccharides, oligosaccharides and polysaccharides. These sugar compounds may be present in different forms in drugs and thei...
See More
-
Tenofovir: full impurity supply
In terms of the human limits of impurities, the International Pharmacopoeia (WHO 11th edition) for tenofovir stipulates the following limits: the area of any peak due to tenofovir monoester (imp...
See More
-
New compound antibiotic - Avibactam
Avibactam is a novel β-lactamase inhibitor used in combination with ceftazidime for the treatment of serious infections caused by drug-resistant gram-negative bacteria. Current research on avibacta...
See More
-
Statin "Top Stream" is Coming - Rosuvastatin Impurities Supply...
The impurity study in its synthesis and quality control is an important part to ensure the safety and efficacy of the drug. Domestic and foreign pharmacopoeias have recorded the impurities of Rosuv...
See More
-
Beda Pharmaceuticals‘ CFT8919 Capsule Clinical Trial Application Acce...
On 9 July, Beda Pharmaceuticals and C4 Therapeutics, Inc. (C4T) received the Notice of Acceptance (Acceptance No. CXHL2400676 and CXHL2400677) from the State Drug Administratio...
See More
-
New Alzheimer‘s drug gets FDA approval for marketing...
The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV infusion), Eli Lilly and Company‘s Alzheimer‘s treatment f...
See More
-
Finerenon,a new diabetic nephropathy drug...
Finerenone has been on the market for a short period of time, and with the accumulation of clinical experience and research evidence, it is expected to bring more benefits to diabetic nephropathy pat...
See More
-
Omadacycline: impurity studies of a new tetracycline antibiotic...
Omadacycline advantageous pathogens wide, can be used for a variety of identified pathogens caused by infections, in addition to the pharmacological mechanism of the study, in the quality control, th...
See More
-
Impurity study of marbofloxacin, the "miracle drug" against influenza...
The main source of impurities in Marbovir is the synthesis side reaction. In the study "Simultaneous determination of three stereoisomers in Marbovir API by reversed-phase high performance liq...
See More